Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hyperion DeFiHYPD -1.08%43 5-Year Yield-on-Cost % is 0.00 as of Jul. 17, 2026. GuruFocus rates HYPD with a GF Score™ of 43/100 and a GF Value™ of $16.53 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 152 Biotechnology companies, Hyperion DeFi ranks worse than 657894.08% on this metric.
Hyperion DeFi's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Hyperion DeFi's 5-Year Yield-on-Cost % or its related term are showing as below:
HYPD's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.73 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Hyperion DeFi 5-Year Yield-on-Cost % Related Terms
HYPD vs MGX, KALA, APLM: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Hyperion DeFi's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hyperion DeFi 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hyperion DeFi's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Hyperion DeFi's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Hyperion DeFi is calculated as
Hyperion DeFi (HYPD) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Hyperion DeFi and its competitors. According to the industry distribution chart, Hyperion DeFi ranks #999999 out of 152 companies in the Biotechnology industry.
Is Hyperion DeFi's 5-Year Yield-on-Cost % too high?
Hyperion DeFi's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Hyperion DeFi ranks #999999 out of 152 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Hyperion DeFi has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hyperion DeFi's 5-Year Yield-on-Cost % compare to MGX and KALA?
According to the Biotechnology industry distribution chart, Hyperion DeFi ranks #999999 out of 152 companies for 5-Year Yield-on-Cost %. This places Hyperion DeFi in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.73, based on 152 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Hyperion DeFi and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hyperion DeFi's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hyperion DeFi stock overvalued right now?
Based on GuruFocus' analysis, Hyperion DeFi (HYPD) is currently considered Possible Value Trap. The stock's GF Value™ is $16.53, compared to a current price of $2.74 — trading 83.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Hyperion DeFi's overall GF Score™ is 43/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Hyperion DeFi (HYPD), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hyperion DeFi (HYPD) Overvalued in 2026?
Based on GuruFocus' analysis, Hyperion DeFi stock appears to be undervalued.
The current stock price of $2.74 is trading 83.4% below its estimated GF Value™ of $16.53.
GuruFocus considers Hyperion DeFi to be Possible Value Trap.
Key valuation signals for HYPD:
5-Year Yield-on-Cost %: 0.00
GF Value™: $16.53 vs. price of $2.74 (83.4% below fair value)
No single metric tells the full story. See the HYPD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hyperion DeFi Inc is a USA-based company building a long-term strategic treasury of Hyperliquid's native token, HYPE. The Company is focused on providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest-growing and highest-revenue-generating blockchains in the world. Shareholders benefit from a gradually compounding exposure to HYPE, both from its native staking yield and additional revenues generated from its on-chain utility. It is working to provide its shareholders with simplified exposure to the Hyperliquid ecosystem, which is believed to be among the highest-revenue-generating blockchains in the world, according to information from various blockchain data tracking sources, including Artemis Analytics and DefiLlama.
43GF Score
Get the complete analysis for HYPD
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HYPD has been successfully added to your 
